BioXcel Therapeutics (NASDAQ:BTAI) reported its Q3 earnings results on Tuesday, November 14, 2023 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
BioXcel Therapeutics missed estimated earnings by 20.61%, reporting an EPS of $-1.58 versus an estimate of $-1.31.
Revenue was up $204 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.08 which was followed by a 4.39% drop in the share price the next day.
Here’s a look at BioXcel Therapeutics’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -1.75 | -1.62 | -1.45 | -1.35 |
| EPS Actual | -1.83 | -1.84 | -1.95 | -1.49 |
| Revenue Estimate | 450K | 500K | 1.25M | 1.09M |
| Revenue Actual | 457K | 206K | 238K | 137K |
To track all earnings releases for BioXcel Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
